Literature DB >> 8616938

Compliance enhancement. A call for multidisciplinary team approaches.

M N Hill, N H Miller.   

Abstract

Mesh：

Year:  1996        PMID： 8616938     DOI： 10.1161/01.cir.93.1.4

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Barriers to hypertension care and control.

Authors:  M N Hill; B S Sutton
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 2.  Medication adherence: a call for action.

Authors:  Hayden B Bosworth; Bradi B Granger; Phil Mendys; Ralph Brindis; Rebecca Burkholder; Susan M Czajkowski; Jodi G Daniel; Inger Ekman; Michael Ho; Mimi Johnson; Stephen E Kimmel; Larry Z Liu; John Musaus; William H Shrank; Elizabeth Whalley Buono; Karen Weiss; Christopher B Granger
Journal:  Am Heart J       Date:  2011-09       Impact factor: 4.749

3.  Compliance and hypertension.

Authors:  F B Garfield; J J Caro
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

4.  Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.

Authors:  Steven M Edworthy; Bonnie Baptie; Donna Galvin; Rollin F Brant; Terry Churchill-Smith; Dante Manyari; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

5.  Diabetes and hypertension guidelines and the primary health care practitioner in Barbados: knowledge, attitudes, practices and barriers--a focus group study.

Authors:  O Peter Adams; Anne O Carter
Journal:  BMC Fam Pract       Date:  2010-12-03       Impact factor: 2.497

6.  Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study.

Authors:  Esther Y T Yu; Eric Y F Wan; Carlos K H Wong; Anca K C Chan; Karina H Y Chan; Sin-Yi Ho; Ruby L P Kwok; Cindy L K Lam
Journal:  J Hypertens       Date:  2017-03       Impact factor: 4.844
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.